Article · 13 Nov 2026
Research articlePublished 19 Jun 2023
Ca 19-9 and Cea Tumor Markers in Blood and Pancreatic Cyst. An Analysis of 134 Patients with Histopathologically Verified Pancreatic Cystic Neoplasms and Non-Neoplastic Cysts
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Pancreatic cystic neoplasms account for approximately 10% of all pancreatic neoplasms and frequency of occurrence increases with age. Among cystic neoplasms, there are benign and malignant lesions. Malignant cysts are mainly diagnosed in the group of mucinous neoplastic cysts (containing mucinous fluid). The current guidelines for the management of asymptomatic pancreatic cystic lesions (consensus) is based mainly on the radiological features of PCL and Endoscopic Ultrasonography with Fine Needle Aspiration (EUS-FNA), which are controversial, mainly due to the limited sensitivity. The histopathological examination in each case concerned the entire lesion (pancreatic resections, local excisions) or a full walled sample (after drainage or palliative operations). However, as shown by the results in this study, the increased concentration of the CEA marker in the fluid does not correlate into an increased concentration in the blood. Although no differences were found in the mean blood concentration of the marker CEA and Ca 19-9 in the study groups, elevated values in the blood of these markers occurred in some cases of MCN, IPMN and non-neoplastic cysts. Tumor markers were determined by Electrohemiluminescence (ECL) using CEA specific biotinylated monoclonal antibodies and Ca 19-9 specific monoclonal antibodies. Mucinous neoplastic cysts, non-mucinous neoplastic cysts and non-neoplastic cysts do not differ in mean blood concentration of tumor markers Ca 19-9 and CEA. Since there is no single, widely used, non-invasive examination that differentiates mucinous neoplastic cysts with high sensitivity and specificity, researchers are moving towards the development of diagnostic systems combining multiple features, which significantly improved differentiation. According to experience of authors of this study, blood concentration of Ca 19-9 and CEA tumor markers should be considered as a rather supplement to the clinical data, imaging test, EUS-FNA and examinations of fluid from PCL.
Keywords
Subjects
Gastroenterology & HepatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of the Pancreas.
Article · 25 Jun 2026
Comparative outcomes of Open and Laparoscopic drainage in Walled off Pancreatic Necrosis
Article · 24 Feb 2026
Xanthogranulomatous Pancreatitis Showing Overlapping
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of the Pancreas
- SubjectGastroenterology & Hepatology
- BylineArticles whose byline prints “Michal Wlazlak”
- BylineArticles whose byline prints “Adam Durczynski”
- BylineArticles whose byline prints “Piotr Hogendorf”
- BylineArticles whose byline prints “Oliwia Grzasiak”
- BylineArticles whose byline prints “Janusz Strzelczyk”